MLA (and various collaboration partners) invests and generates intellectual property. Where applicable, MLA licences technologies with an emphasis on improving the Australian beef, sheep and goat industries.
MLA's passion to innovate and improve industry, coupled with expertise in IP protection and commercialisation, ensures a high level of commercial IP is licenced. We’re energised by potential solutions, no matter how big or how small. Some of the new commercial technology areas include diagnostics, animal treatments, vaccines, remote assessment, waste removal, new energy, robots and genetic assessment.
Below are technologies seeking commercial partners.
The available technology portfolio is constantly changing and not all technologies are advertised. So please contact us if you are exploring solutions to industry problems.
MLA also have strong networks throughout all sectors of industry and are always looking for new ideas to invest in.
Visit the MLA Donor Company for more information.
The University of Queensland (UQ) and Meat & Livestock Australia (MLA) have previously developed a psyllid-resistant Leucaena variety, Redlands. MLA is seeking interest from potential partners to licence to grow out, commercialise, promote and sell seed of Redlands leucaena.
Faecal NIR diagnostics services using dedicated NIRS equations and calibrations for northern pastures.
Automated livestock counting technology for live export yards and vessels, saleyards and farms. (Patent lapsed)
MLA and Queensland University of Technology are seeking partners to further trial and deliver a cattle dags treatment.
MLA and University of Sydney are seeking partners to further trial and deliver a Johne's vaccine for sheep and cattle.
Charles Sturt University and MLA have identified a potential preventative and treatment for Perennial Ryegrass Toxicity.
The Department of Agriculture and Fisheries and MLA have developed an innovative cattle vaccine platform targeted at reducing the incidence of bovine respiratory disease complex (BRDC).
For more information: Rhys Pirie – Business Development Manager
P: +61 (2) 9463 9191, M: +61 421 118 284, E: rpirie@mla.com.au
The Department of Agriculture and Fisheries, University of Queensland and MLA have identified nine novel antigens for use in a vaccine to reduce the incidence of cattle tick.
For more information: Rhys Pirie – Business Development Manager
P: +61 (2) 9463 9191, M: +61 421 118 284, E: rpirie@mla.com.au
MLA are seeking interested partners to further develop and commercialise a novel pain relief pour-on treatment for Australian cattle.
James Cook University, CSIRO and MLA are seeking partners to further trial and test this supplement to reduce methane and increase productivity.
For more information: Rhys Pirie – Business Development Manager
P: +61 (2) 9463 9191, M: +61 421 118 284, E: rpirie@mla.com.au
For use in livestock applications including a intraruminal device.
For more information: Rhys Pirie – Business Development Manager
P: +61 (2) 9463 9191, M: +61 421 118 284, E: rpirie@mla.com.au
For livestock use: an opportunity is available via MLA.
Use of genomic data and algorithms to accurately identify the breed content of individual animals or groups of animals, or tissue samples (such as meat or wool) derived from individual animals or groups of animals.
For more information: Rhys Pirie – Business Development Manager
P: +61 (2) 9463 9191, M: +61 421 118 284, E: rpirie@mla.com.au
For more information: Rhys Pirie – Business Development Manager
P: +61 (2) 9463 9191, M: +61 421 118 284, E: rpirie@mla.com.au
